Close Menu

NEW YORK – Mass spectrometry firm 908 Devices on Thursday priced its initial public offering of 6,500,000 shares at $20 per share for anticipated gross proceeds of $130 million.

Shares of the Boston, Massachusetts-based company will begin trading Friday on the Nasdaq under ticker symbol MASS.

908 Devices is also granting the IPO underwriters a 30-day option to purchase up to an additional 975,000 shares of common stock at the IPO price, less the underwriting discounts and commissions.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.

Nature News writes that scientists are trying to figure out how to name the new strains of SARS-CoV-2 that are emerging.

The New York Times reports that researchers are studying identical twins who had COVID-19 to understand the influence of genetics on disease severity.

In PNAS this week: epistasis affecting cystic fibrosis, Tiger rattlesnake genome gives venom insight, and more.